Human Brain Mapping
October 17, 2020
Feng-Ying Huang, Ai-Ling Hsu, Yi-Ping Chao et al.
Bereavement, the experience of losing a loved one, is one of the most catastrophic but inevitable events in life. It causes grief and intense depression-like sadness. Recent studies have revealed the effectiveness and proficiency of mindfulness-based cognitive therapy (MBCT) in emotional regulation among bereavement populations. MBCT improves the well-being of the bereaved by enhancing...
Acta Psychiatrica Scandinavica
October 9, 2020
M. McCartney, S. Nevitt, Annette Lloyd et al.
To perform a network meta‐analysis (NMA) to compare the long‐term effectiveness of mindfulness‐based cognitive therapy (MBCT) with available strategies for prevention and time to depressive relapse.
Journal of Psychopharmacology
October 8, 2020
Yasmin Schmid, Peter Gasser, Peter Oehen et al.
82 citations
Background: Lysergic acid diethylamide (LSD) and 3,4-methylenedioxymethamphetamine (MDMA) were used in psychotherapy in the 1960s–1980s, and are currently being re-investigated as treatments for several psychiatric disorders. In Switzerland, limited medical use of these substances is possible in patients not responding to other treatments (compassionate use). Methods: This study aimed to...
Journal of Affective Disorders
October 7, 2020
Éva Gál, Simona Stefan, I. Cristea
BACKGROUND Mindfulness applications are popular tools for improving well-being, but their effectiveness is unclear. We conducted a meta-analysis of randomized controlled trials (RCTs) that employed a mindfulness meditation app as the main intervention to improve users' well-being and mental-health related outcomes. METHODS A systematic search was conducted in PsycINFO, PubMed, Web of Science,...
European review for medical and pharmacological sciences
October 2020
N Zareifopoulos, M Lagadinou, A Karela et al.
Antiretroviral drugs are the mainstay of treatment for human immunodeficiency virus (HIV) infection. Lifelong highly active antiretroviral therapy (HAART) is indicated to prevent disease progression to acquired immunodeficiency syndrome (AIDS). Efavirenz was a first-line component of HAART across the world for many years. The purpose of this article is to review the psychotropic properties of...
International Journal of Molecular Sciences
October 1, 2020
M. Bowman, Melissa Vitela, K. Clarke et al.
Major depressive disorder is typically treated with selective serotonin reuptake inhibitors (SSRIs), however, SSRIs take approximately six weeks to produce therapeutic effects, if any. Not surprisingly, there has been great interest in findings that low doses of ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, produce rapid and long-lasting antidepressant effects....
Research in Psychotherapy Psychopathology Process and Outcome
October 1, 2020
Arthur Saniotis
1 citation
Dear Editor, The use of the psychedelic Lysergic Acid Diethylamide (LSD) has again provoked scientific debate over its efficacy and safety. In the 1950s-1960s LSD was used in psychotherapy for treating depression, anxiety related to terminal cancer, addiction, and pain. (...)
Journal of Mental Health Counseling
October 1, 2020
Russ Curtis, Lisen C. Roberts, Elizabeth Graves et al.
28 citations
Psychedelics (i.e., ketamine, methylenedioxymethamphetamine, psilocybin) have been effectively used globally for centuries to treat mental health and addiction issues. However, in the 1950s–1970s, a number of factors, including misuse, abuse, and poorly conceptualized and conducted clinical trials, caused the Federal Drug Administration to classify most of the psychedelic substances as having...
SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português)
September 30, 2020
Nazaré de Oliveira Almeida, Marcelo Demarzo, Carmem Beatriz Neufeld
4 citations
Objetivo: estudo de casos múltiplos teve objetivo de avaliar a aplicabilidade do protocolo de grupo de um programa de 8 semanas de Terapia Cognitiva Baseada em Mindfulness adaptado para o atendimento clínico individual de pacientes com sintomas de depressão. Método: para o estudo de casos múltiplos, no qual 11 casos de pacientes com diagnósticode depressão leve à moderada submetidos à...
Psychiatric News
September 29, 2020
Nicole Harrington Cirino
1 citation
Back to table of contents Previous article Next article ViewpointsFull AccessWait for the Science Before Widespread Use of PsilocybinNicole Harrington Cirino, M.D.Nicole Harrington Cirino, M.D.Published Online:28 Sep 2020https://doi.org/10.1176/appi.pn.2020.10a32AbstractThe momentum behind psilocybin as the next big "breakthrough" in treating psychiatric disorders is strong, but Oregon...